Form 8-K - Current report:
SEC Accession No. 0001213900-25-054784
Filing Date
2025-06-16
Accepted
2025-06-16 16:29:49
Documents
12
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0245924-8k_optimize.htm   iXBRL 8-K 31560
  Complete submission text file 0001213900-25-054784.txt   197253

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE oprx-20250611.xsd EX-101.SCH 3020
3 XBRL LABEL FILE oprx-20250611_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE oprx-20250611_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0245924-8k_optimize_htm.xml XML 3671
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 251050521
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)